2 minute read | October.04.2023
2 minute read | September.15.2023
2 minute read | August.28.2023
Ferring Pharmaceuticals and Royalty Pharma have entered into a royalty agreement for sales of Ferring’s new gene therapy for bladder cancer.
2 minute read | July.20.2023
4 minute read | July.10.2023
1 minute read | June.07.2023
Orrick ranks among Seramount's top 5 firms – and it’s our 15th year on the list.
2 minute read | May.17.2023
Resurrect Bio, a biotech startup using gene editing to protect crops from disease, has completed a seed investment round to fuel its growth.
2 minute read | March.13.2023
2 minute read | March.06.2023
1 minute read | March.02.2023
The proceeds from the financing will be used to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022.
February.15.2023
February.09.2023
